The funding crisis which is paralysing the global biotech sector sees no sign of abating, and more and more companies …
For the European biotech industry, the last few years have seen sustained growth across several fronts – much-needed progress after …
The UK biotech sector says the government's failure to provide urgently needed financial assistance is jeopardising its future.Industry body the …
Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …
Merck Serono has set up a venture capital fund to invest in emerging biotech companies working in its core therapy …
Around one in five European biotech companies could go bust by the end of 2009 if new funding doesn't emerge …
Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …
Cash-stricken UK biotech has been left hanging on for government funding, without any guarantee it will get the support needed. …
The credit crunch hits biotechBy October Europe's biotech sector was feeling severe effects from the credit crunch, with small and …
Biotech leaders in the UK say the cash-stricken industry has reached 'breaking point', and have made an unprecedented plea for …
Bioscience leaders from both sides of the Atlantic have joined in a war game that could help boost the UK …
Oxford BioMedica has settled on a permanent chief executive, promoting John Dawson from his acting leadership position. Chairman professor Alan …
Europe’s biotech sector is being hit hard by the credit crunch, with small and medium-sized companies being starved of funding …
Monoclonal antibody sales to almost double by 2013In 2007, total global monoclonal antibody sales reached $26 billion and are forecast …